CYP2A19 - cytochrome P450 family 2 subfamily A member 19 Gene
Also Known as CYP2A; CYP2A6
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 403149
CYP2A19 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_214417.1 | NP_999582.1 | cytochrome P450 family 2 subfamily A member 19 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cytochrome P450 family 2 subfamily A member 19 |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-17356 | Fenofibrate | 99.97% | Yes | |
| HY-103392 | Stiripentol | Inhibitor | 99.99% | Yes |
| HY-B0113 | Omeprazole | Inhibitor | 99.96% | Yes |
| HY-17459 | Clopidogrel hydrogen sulfate | Inhibitor | 99.88% | Yes |
| HY-100386 | Ticlopidine | Inhibitor | 99.74% | Unkown |
| HY-B0113A | Omeprazole sodium | Inhibitor | 99.10% | Yes |
| HY-B0153A | Ticlopidine hydrochloride | Inhibitor | 99.99% | Unkown |
| HY-B1184 | Mephenytoin | 99.96% | Unkown | |
| HY-B0113R | Omeprazole (Standard) | Inhibitor | 99.86% | Unkown |
| HY-109546 | Omeprazole magnesium | Inhibitor | / | Unkown |
| HY-17459R | Clopidogrel hydrogen sulfate (Standard) | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-116780 | Prothipendyl | Substrate | / | Phase 3 |
| HY-50845 | Avagacestat | Inhibitor | 99.92% | Phase 2 |
| HY-19397 | BMS-223131 | / | Phase 2 | |
| HY-12946 | BI 653048 | Inhibitor | 99.84% | Phase 1 |
| HY-12946A | BI 653048 phosphate | Inhibitor | / | Phase 1 |
| HY-19379 | E-2101 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(73)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B1184A | (S)-Mephenytoin | 99.94% | Unkown | |
| HY-W008772 | 4-Hydroxymephenytoin | 99.77% | Unkown | |
| HY-W008364 | Olivetol | Inhibitor | 99.84% | Unkown |
| HY-W013268 | (S)-(+)-N-3-Benzylnirvanol | Inhibitor | 99.76% | Unkown |
| HY-N0762 | Isobavachin | 99.88% | Unkown | |
| HY-W008772S | 4-Hydroxymephenytoin-d3 | 99.05% | Unkown | |
| HY-131968 | BMS-986202 | Inhibitor | 99.29% | Unkown |
| HY-137258 | (±)-N-3-Benzylnirvanol | Inhibitor | 99.86% | Unkown |
| HY-B1184AR | (S)-Mephenytoin (Standard) | 99.93% | Unkown | |
| HY-170538 | SNT-5382 | Inhibitor | 99.96% | Unkown |
| HY-N0920 | Dihydrokavain | Inhibitor | 99.94% | Unkown |
| HY-N1050 | Zederone | Inhibitor | 99.61% | Unkown |
| HY-129923 | (R)-Omeprazole sodium | Inhibitor | 98.07% | Unkown |
| HY-118283 | 5-Hydroxylansoprazole | Inhibitor | 99.75% | Unkown |
| HY-116862 | Dibenzylfluorescein | 99.54% | Unkown | |
| HY-B0113S | Omeprazole-d3 | Inhibitor | 98.99% | Unkown |
| HY-147294 | Nivasorexant | 99.74% | Unkown | |
| HY-17356R | Fenofibrate (Standard) | 99.92% | Unkown | |
| HY-W157689 | IDE-IN-2 | Inhibitor | 98.04% | Unkown |
| HY-W587878 | Thujopsene | 86.31% | Unkown | |
| HY-116780A | Prothipendyl hydrochloride | Substrate | 99.94% | Unkown |
| HY-126857 | 5-Hydroxyomeprazole | ≥96.0% | Unkown | |
| HY-17356S | Fenofibrate-d6 | 99.70% | Unkown | |
| HY-B0113S3 | Omeprazole-13C,d3 | Inhibitor | 98.00% | Unkown |
| HY-N5132 | (-)-Fenchone | 98.0% | Unkown | |
| HY-124542 | 5-Hydroxydiclofenac | Inducer | 99.52% | Unkown |
| HY-135111 | 4-Desmethoxy Omeprazole | 98.99% | Unkown | |
| HY-155732 | NPD-2975 | Inhibitor | 98.40% | Unkown |
| HY-186072 | NT-0527 | 99.80% | Unkown | |
| HY-B1184S1 | Mephenytoin-d5 | 98.72% | Unkown | |
| HY-N6023 | Thermopsoside | 98.0% | Unkown | |
| HY-100386S | Ticlopidine-d4 | Inhibitor | / | Unkown |
| HY-135111S | 4-Desmethoxy Omeprazole-d3 | / | Unkown | |
| HY-103392S | Stiripentol-d9 | Inhibitor | / | Unkown |
| HY-116811 | AZ-11665362 | / | Unkown | |
| HY-137258A | (R)-N-3-Benzylnirvanol | Inhibitor | / | Unkown |
| HY-147807 | HIV-1 inhibitor-40 | Inhibitor | / | Unkown |
| HY-148597 | FGFR-IN-10 | Inhibitor | / | Unkown |
| HY-149866 | HIV-1 inhibitor-58 | Inhibitor | / | Unkown |
| HY-151251 | CYP2C9/CYP2C19-IN-1 | Inhibitor | / | Unkown |
| HY-151253 | CYP2C1/CYP2C19-IN-2 | Inhibitor | / | Unkown |
| HY-151254 | CYP2C19-IN-1 | Inhibitor | / | Unkown |
| HY-159143 | BChE-IN-33 | Inhibitor | / | Unkown |
| HY-163816 | Antiproliferative agent-53-d3 | Inhibitor | / | Unkown |
| HY-166530S | Ticlopidine-d6 hydrochloride | Inhibitor | / | Unkown |
| HY-172393 | TCF4/β-catenin-IN-1 | / | Unkown | |
| HY-17356G | Fenofibrate (GMP) | / | Unkown | |
| HY-17356S1 | Fenofibrate-d4 | / | Unkown | |
| HY-17459S | Clopidogrel-d3 hydrogen sulfate | / | Unkown | |
| HY-178786 | RET-IN-31 | Inhibitor | / | Unkown |
| HY-179154 | α-Glucosidase-IN-101 | Inhibitor | / | Unkown |
| HY-182012 | DT-678 | / | Unkown | |
| HY-182602 | KOSN 1724 | Inhibitor | / | Unkown |
| HY-B0113S1 | Omeprazole-d3-1 | Inhibitor | 95.09% | Unkown |
| HY-B0153AS | Ticlopidine-d4 hydrochloride | Inhibitor | / | Unkown |
| HY-B1184S2 | Mephenytoin-d8 | / | Unkown | |
| HY-B1184S3 | Mephenytoin-13C,d3 | / | Unkown | |
| HY-N20617 | (2E,6E,10E)-12-Hydroxyfarnesol | / | Unkown | |
| HY-RS03458 | CYP2C19 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W008364S1 | Olivetol-d9 | / | Unkown | |
| HY-W140208 | 3-Phenylthiophene | Inhibitor | / | Unkown |
| HY-W663179 | DNDI-VL-2098 | Inhibitor | / | Unkown |
| HY-W707554 | Ticlopidine hydrochloride-d6 | / | Unkown | |
| HY-169119 | Antifungal agent 114 | Inhibitor | / | Unkown |
| HY-17356S2 | Fenofibrate-13C6 | / | Unkown | |
| HY-175169 | Urease-IN-21 | Inhibitor | / | Unkown |
| HY-175804 | M2 ion channel blocker-2 | Inhibitor | / | Unkown |
| HY-B0113S2 | Omeprazole sulfone (methoxy-d3) | Inhibitor | 99.70% | Unkown |
| HY-B0113S4 | Omeprazole-d3 sodium | Inhibitor | / | Unkown |
| HY-B0113S5 | Omeprazole-d6 | Inhibitor | / | Unkown |
| HY-B1184S | Mephenytoin-d3 | 99.52% | Unkown | |
| HY-W587570 | (S)-4-Hydroxymephenytoin | / | Unkown | |
| HY-W702646 | Hydroxymethyl tolperisone hydrochloride | Control | / | Unkown |